RxDoctor Payments Data

Amber Poirot, DPM

Podiatrist · Metairie, LANPI 1275885295

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 38 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 14 manufacturers, the largest accounting for just 23.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $1,180 and has fallen 78.3% since, to $255 in 2025. That places this record below the midpoint for podiatrist clinicians in LA, where the typical reported total is $2,398.

$2,513in general payments, 2019–2025

Across 38 payments — averaging $66.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organogenesis Inc.$578
  • Stryker$560
  • Kerecis Limited$369
  • Hydrofera LLC$284
  • Bone Support Inc.$143
  • Hartmann USA, Inc.$137
  • plus $443 from 8 others

What the payments were for

  • Food & beverage$2,513100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,513 in reported general payments places this provider in the 50th percentile of 68 podiatrist providers in Louisiana.

See all podiatrist providers in Louisiana

Medicare billing

Part B allowed, 2024
$77,409
Medicare patients
144
Services billed
1,031

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tobramycin Sulfate14$21,153
Gentamicin Sulfate26$1,023
Ciprofloxacin Hcl25$346
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav11$177
Doxycycline Hyclate11$86
Tramadol Hcl12$82
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen12$47

Paid to pharmacies, not to this prescriber.

Other podiatrist in Metairie

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →